Home » Topics » Deals and M&A » Collaboration

Collaboration
RSS

BioRelix and Merck & Co. subsidiary partner to identify antibacterial drug candidates

Oct. 7, 2010

Evotec and Shionogi form multiple-target drug discovery alliance

Oct. 6, 2010

DSP and SanBio develop new stem cell therapy for stroke

Oct. 6, 2010

Noven acquires Daytrana methylphenidate transdermal system from Shire

Oct. 6, 2010

Meda acquires erectile dysfunction therapy Muse from Vivus

Oct. 6, 2010

Brain Factory gains Japanese rights to Eisai's ravuconazole prodrug

Oct. 6, 2010

Lundbeck acquires exclusive rights to KW-6356 from Kyowa Hakko Kirin

Oct. 6, 2010

Cortex Pharma regains rights to Ampakine agents for depression and schizophrenia

Oct. 5, 2010

Argenta and Janssen enter into cancer drug discovery agreement

Oct. 5, 2010

Eisai and Anaeropharma partner to discover Bifidobacterium-delivered anticancer agents

Oct. 5, 2010

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 29, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for May 26, 2026
TROP2 ADCs progress into first-line for lung, breast cancers
BioWorld
Multiple updates on TROP2-directed antibody-drug conjugates (ADCs) for lung and breast cancers highlight both progress made and opportunities for improvement for...
Researchers identify innate immune barrier against melanoma
BioWorld
Australian researchers have identified a previously overlooked population of immune cells in the skin that physically restrain melanoma growth by engulfing live...
Cavalon Therapeutics and Northwestern patent new Cav1.3 blockers
BioWorld Science
Cavalon Therapeutics Inc. and Northwestern University have disclosed new voltage-gated calcium channel Cav1.3 blockers potentially useful for the treatment of...